Abstract
Safe blood transfusion is the primary need of all the health care delivery system. Though with the advances of transfusion medicine, the incidences of transfusion risk is gradually reduced, but the adverse transfusion reaction (ATR) of non hemolytic type still prevails. The purpose of this study was to estimate the incidence and pattern of transfusion-related adverse events at our centre. The present retrospective observational study was conducted in the Department of Transfusion Medicine from April 2011 to April 2018, at a multi-organ transplant centre in South India. All the Adverse transfusion reactions were investigated in detail in the blood bank for the clerical errors, immunohematology workup and classified according to their nature with imputability assessment. A total of 140 ATR were reported out of 100,569 blood components distributed during the study period. After the analysis and workup of the reported reactions, majority of the reactions were observed in males (71%, n = 99). Most common symptom presented was Itching/Rashes in 43.6% (n = 61) ATR. Allergic reactions (51.4%, n = 72), were the most commonly encountered ATR followed by FNHTR (25.7%, n = 36). FFP transfusions (0.2%) contributed to the majority of the reactions followed by Red cell transfusion (0.15%). ATR were observed maximum in Hepato-biliary disease and liver transplantation patients (62%) followed by oncology patients (15%). The overall incidence of ATR in our study is 0.14% which is comparatively low compared to other studies due to well established hemovigilance systems. Adoption of more equipped methods & sensitive technology in various areas of blood banking will help to bring down the unwanted adverse transfusion reactions.
Similar content being viewed by others
References
Andreu G, Morel P, Forestier F, Debeir J, Rebibo D, Janvier G et al (2002) Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Transfusion 42:1356–1364
Robillard P, Karl Itaj N (2002) Incidence of adverse transfusion reactions in the Quebec Hemovigilance System. Vox Sang 83:120
Mazzezi CA, Popovsky MA, Kopko PM (2014) Non infectious complications of blood transfusion. In: Fung MK (ed) Technical manual, 18th edn. American Association of Blood Bank, Bethesda, pp 685–695
Philip J, Pawar A, Chatterjee T, Malhi RS, Biswas AK, Dimri U (2015) Non infectious complications related to blood transfusion: an 11 year retrospective analysis in a tertiary care hospital. Indian J Hematol Blood Transfus 32:292–298
Fumiya H (2013) Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol 160(4):434–444
Savage WJ, Tobian AA, Savage JH, Hamilton RG, Ness PM (2011) A topic predisposition of recipients in allergic transfusion reactions to apheresis platelets. Transfusion 51:2337–2342
Domen RE, Hoeltge GA (2003) Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med 127:316–320
Sandler SG, Mallory D, Malamut D, Eckrich R (1995) IgA anaphylactic transfusion reactions. Trans Med Rev 9(1):1–8
Matsuyama N, Hirayama F, Wakamoto S, Yasui K, Furuta RA, Kimura T et al (2009) Application of the basophil activation test in the analysis of allergic transfusion reactions. Transfus Med 19:274–277
Hirayama F (2010) Recent advances in laboratory assays for nonhemolytic transfusion reactions. Transfusion 50:252–263
Sandler SG, Vassallo RR (2011) Anaphylactic transfusion reactions. Transfusion 51:2265–2266
Burks AW, Sampson HA, Buckley RH (1986) Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med 314:560–564
Harper JL, Gill JC, Hopp RJ, Evans J, Haire WD (1995) Induction of immune tolerance in a 7-year-old hemophiliac with an anaphylactoid inhibitor. Thromb Haemost 74:1039–1041
Kumar P, Thapliyal R, Coshic P, Chatterjee K (2013) Retrospective evaluation of adverse transfusion reactions following blood product transfusion from a tertiary care hospital: a preliminary step towards hemovigilance. Asian J Transfus Sci 7:109–115
Bhattacharya P, Marwaha N, Dhawan HK, Roy P, Sharma RR (2011) Transfusion-related adverse events at the tertiary care center in North India: an institutional hemovigilance effort. Asian J Transfus Sci 5:164–170
Sharma DK, Datta S, Gupta A (2015) Study of acute transfusion reactions in a teaching hospital of Sikkim: a hemovigilance initiative. Indian J Pharmacol 47:370–374
Bassi R, Aggarwal S, Bhardwaj K, Thakur KK (2017) Patterns of adverse transfusion reactions in a tertiary care centre of North India: a step towards hemovigilance. Indian J Hematol Blood Transfus 33:248–253
Pahuja S, Puri V, Mahajan G, Gupta P, Jain M (2017) Reporting adverse transfusion reactions: a retrospective study from tertiary care hospital from New Delhi, India. Asian J Transfus Sci 11:6–12
Hendrickson JE, Roubinian NH, Chowdhury D, Brambilla D, Murphy EL, Wu Y et al (2016) Incidence of transfusion reactions: a multi-center study utilizing systematic active surveillance and expert adjudication. Transfusion 56:2587–2596
Blumberg N, Heal JM, Gettings KF, Phipps RP, Masel D, Refaai MA et al (2010) An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 50:2738–2744
Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, The National Heart Lung and Blood Institute Working Group on TRALI et al (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33:721–726
Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA (2005) Proceedings of a consensus conference: towards and understanding of TRALI 2005. Transfus Med Rev 19:2–31
Triulzi DJ (2009) Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 108:770–776
Erwin S (2008) Hemolytic transfusion reactions. Transfus Med Hemother 35:346–353
Beauregard P, Blajchman MA (1994) Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev 8(3):184–199
Payandeh M, Zare ME, Kansestani AN et al (2013) Descriptions of acute transfusion reactions in the teaching Hospitals of Kermanshah University of Medical Sciences, Iran. Int J Hematol Oncol Stem cell Res 7:11–16
Mafirakureva N, Khoza S, Mvere DA, Chitiyo ME, Postma MJ, Van Hulst M (2014) Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis. Blood Transfus. 12:362–367
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
All procedures were done in accordance of ethical standards. Informed Consent was taken from the patient before blood transfusion.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Saha, S., Krishna, D., Prasath, R. et al. Incidence and Analysis of 7 Years Adverse Transfusion Reaction: A Retrospective Analysis. Indian J Hematol Blood Transfus 36, 149–155 (2020). https://doi.org/10.1007/s12288-019-01174-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-019-01174-x